JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Evaluation of Acute Severe Ulcerative Colitis Predictors for Steroid Therapy Refractoriness

  • 0Faculty of Medicine, Alexandria University, Alexandria, Egypt. a_anwar141@alexmed.edu.eg.
Digestive Diseases and Sciences +

|

April 5, 2025

|

April 5, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Identifying patients with acute severe ulcerative colitis (ASUC) who will not respond to steroids is key. Lower albumin and prior oral steroid use predict steroid failure in ASUC, suggesting early advanced therapy.

Area Of Science

  • Gastroenterology
  • Internal Medicine
  • Clinical Research

Background

  • Acute severe ulcerative colitis (ASUC) affects many patients, with one-third being steroid-refractory.
  • Steroid-refractory patients often require colectomy or rescue therapy.
  • Early identification of non-responders is crucial for timely intervention.

Purpose Of The Study

  • To identify predictive factors for steroid failure in ASUC.
  • To determine factors associated with colectomy in ASUC patients.

Main Methods

  • Retrospective analysis of 103 ASUC admissions.
  • Collected clinical, laboratory, and endoscopic data at admission.
  • Used regression analyses to identify predictors of non-response to intravenous steroids.

Main Results

  • 51 out of 103 patients were steroid non-responders.
  • Lower day-one albumin and pre-admission oral steroid use predicted non-response.
  • Travis criteria predicted both steroid non-response and colectomy.

Conclusions

  • Lower albumin levels and prior oral steroid use predict intravenous steroid failure in ASUC.
  • Suggests early initiation of advanced therapy for this high-risk subgroup.

Keywords:

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids 01:21

91

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...

Drugs for Treatment of Ulcerative Colitis in IBD 01:29

110

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...

Inflammatory Bowel Disease IV: Pharmacological Management 01:29

82

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy 01:30

259

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease I: Ulcerative Colitis 01:27

99

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents 01:29

109

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...